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Bone morphogenetic proteins (BMPs) have diverse
functions during development in vertebrates. We
have recently shown that BMP2 signaling promotes
venous-specific angiogenesis in zebrafish embryos.
However, factors that confer a context-dependent
proangiogenic function of BMP2 signaling within
endothelial cells need to be identified. Here, we
report that Disabled homolog 2 (Dab2), a cargo-
specific adaptor protein for Clathrin, is essential to
mediate the proangiogenic function of BMP2
signaling. We find that inhibition of Dab2 attenuates
internalization of BMP receptors and abrogates the
proangiogenic effects of BMP signaling in endothe-
lial cells. Moreover, inhibition of Dab2 decreases
phosphorylation of SMAD-1, 5, and 8, indicating
that Dab2 plays an essential role in determining the
outcome of BMP signaling within endothelial cells
and may provide a molecular basis for a context-
dependent proangiogenic function of BMP2
signaling.
INTRODUCTION
Endocytosis is essential for a variety of cellular and physiological
processes. In many cases, activated receptors undergo
‘‘receptor-mediated endocytosis’’ upon ligand binding, which
modifies the duration and strength of the response within cells
allowing context-dependent signaling (Dobrowolski and De
Robertis, 2011; Le Roy and Wrana, 2005; Shilo and Schejter,
2011). This process is regulated by arrays of adaptor molecules
that link membrane-bound proteins (cargo) with Clathrin-coated
pit (CCP) (Reider andWendland, 2011; Traub, 2009). Internalized
receptors can be retained within endosomal compartments to
prolong signaling or can undergo rapid degradation, which
results in attenuation of the signaling (Di Guglielmo et al., 2003;
Platta and Stenmark, 2011).DevelopBy selectively associating with distinct cargo-specific adaptor
molecules and coreceptors, activated receptors can change
internalization and subsequent intracellular trafficking routes.
This allows signal-receiving cells to produce distinct context-
dependent responses to the same signal. For instance, activated
vascular endothelial growth factor receptor 2 (VEGFR2), the
main receptor for VEGF-A, generates distinct responses in
endothelial cells depending on the auxiliary molecules. While
Synectin-MyosinVI complex-dependent trafficking of VEGFR2
facilitates arteriogenesis in mice and zebrafish (Lanahan et al.,
2010), EphrinB2-dependent internalization of VEGFR2 or R3
promotes developmental angiogenesis in mice (Sawamiphak
et al., 2010; Wang et al., 2010).
Disabled homolog 2 (DAB2), which was first identified as the
gene downregulated in ovarian cancer and ovarian carcinoma
cell lines (Mok et al., 1994), has been proposed as a cargo-
specific adaptor protein for Clathrin (Gallagher et al., 2004; Mis-
hra et al., 2002). For instance, DAB2 can bind to transforming
growth factor beta (TGF-b) type I and type II receptors and regu-
late TGF-b signaling activity (Di Guglielmo et al., 2003; Hocevar
et al., 2001; Penheiter et al., 2010). In addition, DAB2 has been
shown to interact with Megalin, Cublin, and Transferrin (Maurer
and Cooper, 2005; Morris et al., 2002). During murine develop-
ment, expression of Dab2 is detected in the primitive endoderm
and contributes to the formation of the inner cell mass (Yang
et al., 2002). In accordance with the early expression pattern,
a targeted deletion of Dab2 causes embryonic lethality before
E6.5 (Morris et al., 2002; Yang et al., 2002), indicating that
DAB2 function is essential for early development. In addition,
analyses with conditional knockouts revealed that Dab2 function
is essential for trafficking of Megalin (Morris et al., 2002). In ze-
brafish, dab2 is expressed within venous endothelial cells, otic
vesicles, and pronephric ducts (Sprague et al., 2006). In addition,
Morpholino (MO)-mediated knockdown studies on dab2 show
that Dab2 is essential formetabolite uptakewithin the pronephric
duct (Anzenberger et al., 2006).
We have recently demonstrated that bone morphogenetic
protein 2 (Bmp2) signaling can function as a context-dependent
proangiogenic cue in zebrafish embryos. Activation of Bmp2b,
a zebrafish ortholog of BMP2, induces ectopic angiogenesis
only from venous endothelial cells (Wiley et al., 2011). To bettermental Cell 23, 441–448, August 14, 2012 ª2012 Elsevier Inc. 441
Figure 1. Dab2 Mediates Venous-Specific Proangiogenic Function of Bmp2b
(A) Fluorescence in situ for dab2 and immunostaining for kdrl:GFP and DAPI. Lateral view (top) and transverse section (bottom). Scale bar is 200 mm (top) or 10 mm
(bottom). DA, dorsal aorta; CV, cardinal vein. See also Figure S1A.
(B) Depth-coded images of control or dab2MO-injected 45 hpf wild-type (WT) and Bmp2b overexpressing (Bmp2) embryos. XZ and YZ axis views of each image
are also shown. Arrows point to ectopic vessels in the projection. Images were obtained between the 16th and 20th somite. Scale bar is 100 mm. DA, dorsal aorta;
DV, dorsal vein; VV, ventral vein. See also Figures S1B–S1F.
(C) Quantification. The number of branches (n = 3, total number of embryos was 19 [Bmp2b] or 17 [Bmp2b/dab2MO], **p < 0.001) and vessel surface as assessed
by mean GFP pixel intensity (n = 3, total number of embryos was 21 [Bmp2b] or 19 [Bmp2b/dab2 MO], **p < 0.001). Error bars represent standard error of the
mean (SEM).
(D) Fluorescent images of 26 hpf control (top) or dab2 (bottom) MO-injected embryos. Arrowheads point to ventral sprouts. Scale bar is 100 mm.
(E) Quantification of ventral sprouts in the CVP (n = 3, total number of embryos was 25 [Control] or 20 [dab2 MO], **p < 0.001). Error bars represent SEM.
(F) Fibrin gel assay of control and DAB2 siRNA-treated HUVECs. Scale bar is 10 mm. See also Figures S1G and S1H.
(G) Quantification of vascular coverage and diameter. Values were normalized to control siRNA treatment sample by PRISM program. n = 3 and *p < 0.05. Error
bar is SEM.
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Dab2 Mediates BMP Signaling in Endothelial Cellsunderstand themolecular basis of Bmp2b-induced angiogenesis
within venous endothelial cells, we screened for endothelial-
specific factors that facilitate venous-specific responses to
Bmp2b signaling and identified Dab2 as a key modulator. In
this report, we show that Dab2 is required for the formation of
the caudal vein plexus (CVP) and is physically associated with
BMP type II receptor (BMPRII). In addition, we demonstrate
that DAB2 promotes internalization of the BMP2 ligand receptor
complex, which in turnmodulates downstreamSMADactivation.
Taken together, our data suggest that DAB2-mediated endocy-
tosis of the BMP2 ligand-receptor complex is essential for the
context-dependent proangiogenic property of BMP2 signaling.
RESULTS AND DISCUSSION
Dab2 Is a Venous-Specific Modulator of Bmp2b
Signaling
To identify factors that confer venous specificity of Bmp2b-
mediated angiogenesis in zebrafish embryos, we first assessed442 Developmental Cell 23, 441–448, August 14, 2012 ª2012 Elseviethe function of genes preferentially expressed within venous
endothelial cells during the formation of the CVP by MO-medi-
ated gene knockdown. One of the candidates, dab2, is selec-
tively expressed within developing veins, pronephric ducts,
and otic vesicles as previously reported (Anzenberger et al.,
2006; Sprague et al., 2008) (Figure S1A available online). Consid-
ering the association of Dab2 with TGF-b signaling (Di Guglielmo
et al., 2003), we chose to investigate the function of Dab2 in
mediating Bmp2b signaling. Endothelial expression of dab2
becomes apparent at 24 hr postfertilization (hpf) in both arterial
and venous endothelial cells, and its expression is gradually
restricted to venous endothelial cells between 32 and 48 hpf (Fig-
ure 1A; Figure S1A).
To examine the function of Dab2 during vascular development,
the phenotype of dab2 MO-injected embryos was assessed.
While theoverall vascular structureofdab2MO-injectedembryos
was comparable to control MO-injected embryos, the CVP failed
to form, reminiscent of bmpr2a or bmpr2aMO-injected embryos
(Wiley et al., 2011) (Figures S1B and S1C; Movie S1). Tor Inc.
Figure 2. Dab2 Functionally Interacts with
Bmp2b Signal to Promote Caudal Vein
Plexus Formation
(A) Fluorescent images of 32 hpf control, dab2,
bmpr2a, and dab2/bmpr2aMO-injected embryos.
Arrowheads point to the regions that fail to
connect to neighboring sprouts. Scale bar is
100 mm. See also Figure S2A.
(B) Quantification of ventral vein (VV) defects. n =
3, and total number of embryos was 54 (control),
32 (bmpr2a MO), 26 (dab2 MO), or 35 (dab2/
bmpr2aMO). p < 0.001 in all cases, except p value
against dab2 MO-injected embryos, where p =
0.05. *comparison with control MO-injected
embryos; **comparison with bmpr2a MO-injected
embryos; and ***comparison with dab2 MO-in-
jected embryos. Error bars represent SEM.
(C) Confocal micrographs of control or dab2 MO-
injected 45 hpf Tg(hsp70l:bmp2b) embryos,
showing p-Smad-1,5/8 (red) and endothelial cells
(green). Arrowheads point to p-Smad-1,5/8 within
venous endothelial cells. Scale bar is 100 mm.
(D) Confocal micrographs of control or dab2
MO-injected 45 hpf Tg(BRE:GFP);Tg(fli1:DsRed)
embryos. Arrowheads point to GFP expression by
BRE. Scale bar is 100 mm. DA, dorsal aorta; DV,
dorsal vein; VV, ventral vein.
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signaling, we examined the extent of Bmp2b-mediated angio-
genesis in the presence and absenceof functional Dab2.Overex-
pression of bmp2b induced robust angiogenesis from venous
endothelial cells in controlMO-injectedembryosaspreviously re-
ported (Wiley et al., 2011) (Figure 1B). These ectopic vessels
strongly expressed dab2 and stab2, indicating their venous iden-
tity (Wong et al., 2009) (Figure S1D). In contrast, the number of
Bmp2b-induced ectopic vessels was drastically reduced in
dab2MO-injected embryos (Figures 1B, 1C, and S1D), indicating
that Dab2 function is essential for mediating the proangiogenic
function of Bmp2b within venous endothelial cells.
Previously, factors that mediate BMP signaling in a tissue-
specific manner, such as Cysteine-rich motor neuron 1 protein
(CRIM1) (James and Broihier, 2011) and Jiraiya (Aramaki et al.,
2010), have been identified. Considering the expression pattern
of dab2 in zebrafish and themild phenotype of dab2MO-injected
embryos (Figure S1B), Dab2 is likely to mediate Bmp2b signaling
in a spatiotemporally restricted manner. To test this idea, we
examined whether inactivation of Dab2 at earlier stages can
ameliorate axis defects caused by excessive Bmp2b signaling
(Figures S1E and S1F). In both control and dab2 MO-injected
embryos, an excessive level of BMP activity early on caused
severe ventralization, suggesting that Dab2 is dispensable for
Bmp2b signaling during axis formation. Therefore, Dab2 does
not appear to be a generic modulator of Bmp2b signaling during
development.
Dab2 Is Required for the Angiogenesis of Venous
Endothelial Cells
Next, the phenotype of dab2 MO-injected embryos was exam-
ined at distinct development stages (Figure S2A). While controlDevelopMO-injected embryos displayed stereotypic angiogenesis in
the CVP as previously reported (Wiley et al., 2011), the initial
formation of ventral sprouts was severely disrupted in dab2
MO-injected embryos, resulting in a drastically reduced number
of ventral sprouts (Figures 1D and 1E). At 32 hpf, dab2
MO-injected embryos failed to form a distinct dorsal and ventral
veins (Figure 2A; Figure S2A). Therefore, Dab2 appears to be
essential for the formation of CVP.
In human umbilical vein endothelial cells (HUVECs), DAB2
appears to have a similar function in promoting angiogenesis.
In Fibrin gel assay, vascular coverage and the diameter of the
vessel were significantly decreased in DAB2 siRNA-treated
HUVECs in the absence of VEGF-A (Figures 1F, 1G, and S1G).
Upon VEGF-A stimulation, DAB2 siRNA-treated HUVECs dis-
played an increased vascular coverage, indicating that these
cells were capable of responding to VEGF-A signaling (Fig-
ure S1H). The relative increase in vascular coverage and diam-
eter by VEGF-A stimulation is comparable in control or DAB2
siRNA-treated HUVECs (Figure S1H).
Dab2 Is Essential for BMP2-Mediated SMAD Activity
The CVP phenotype observed in dab2 MO-injected embryos is
strikingly similar to those found in embryos with compromised
Bmp2b signaling (Wiley et al., 2011) (Figure S2A) and is more
severe than the phenotype of bmpr2a MO-injected embryos
(Figures 2A and 2B), consistent with the idea that Bmpr2a
and Bmpr2b have a partially redundant function in CVP forma-
tion (Wiley et al., 2011). Moreover, coinjection of dab2 and
bmpr2a MO enhanced the defects (Figures 2A and 2B),
suggesting that Dab2 and BMP type II receptors may function-
ally interact to mediate BMP signaling in venous endothelial
cells.mental Cell 23, 441–448, August 14, 2012 ª2012 Elsevier Inc. 443
Figure 3. DAB2 Interacts with BMP Type II Receptor and Clathin
(A) Representative images of control or DAB2 siRNA-treated HUVECs plated on Fibrin gel in the presence or absence of 50 ng/ml of BMP6. Arrows point to
vascular tube with an increased diameter. Scale bar is 200 mm.
(B) Quantification of (A). Vascular coverage and diameter were evaluated by PRISM program. n = 3 and *p < 0.05. Error bar is SEM.
(C) Immunocytochemistry detecting DAB2, BMPRII, and Clathrin in HUVECs. Insets are taken from the areas within the rectangles in the left column. Arrows point
to colocalization. Scale bar is 10 mm. See also Figures S3A–S3C.
(D) Proximity ligation assay using antibodies against DAB2 and BMPRII in control (top) or DAB2/BMPRII siRNA-treated (bottom) HUVECs, counterstained with
DAPI (blue) and phalloidin (green). Scale bar is 10 mm. See also Figures S3D and S3E.
(E) Quantification of PLA signals of (D). n = 3, and total number of images was 17 for control or target siRNA treatment. **p < 0.005 and error bar presents SEM.
(F) Coimmunoprecipitation assay using DAB2 antibody. DAB2 antibody was able to pull down BMPRII from HUVEC lysate.
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Dab2 Mediates BMP Signaling in Endothelial CellsTo elucidate the function of Dab2 in Bmp2b signaling, we
examined the effects of Dab2 inhibition on SMAD activation
within endothelial cells. The presence of phosphorylated SMADs
can be detected in a subset of endothelial cells in Bmp2b over-
expressing embryos. However, dab2 MO injection completely
abolished phosphorylation of SMAD in endothelial cells (Fig-
ure 2C), indicating that Dab2 is an essential component of
Bmp2b signaling. Similarly, the activity of the BMP response
element (BRE) was abrogated in dab2 MO-injected Tg(BRE:
GFP)pt510 (Laux et al., 2011) embryos (Figure 2D).
DAB2 Is Essential for Angiogenic Activity of BMP6 in
HUVECs
Considering that knockdown of dab2 drastically decreased
phosphorylation of SMADs and BRE activity, Dab2 function
appears to be essential for BMP2 signaling in zebrafish. To
examinewhether DAB2 has a similar role inmammalian systems,
we utilized HUVECs. As in mice (Maurer and Cooper, 2005; Xu
et al., 1995), two isoforms of DAB2 are present in HUVECs,
with the larger, predominantly expressed form corresponding
to the p96 isoform found in mouse (Figure S1G). To interrogate444 Developmental Cell 23, 441–448, August 14, 2012 ª2012 Elseviethe function of DAB2 in BMP signaling, we treated HUVECs
with DAB2 siRNA that preferentially blocks the larger isoform
(Figure S1G) and evaluated phenotypes of control and DAB2
siRNA-treated HUVECs on VEGF-A containing Fibrin gel in the
presence and absence of BMP6. BMP6 was used since it elicits
a robust response in Fibrin gel assay, and it activates the same
sets of BMP type I receptors as BMP2 (Morikawa et al., 2011;
Valdimarsdottir et al., 2002). In control siRNA-treated HUVECs,
BMP6 treatment increased vessel diameter without affecting
the vascular coverage. However, the effect of BMP6 was abro-
gated in DAB2 siRNA-treated HUVECs (Figures 3A and 3B,
arrows).
Considering the effects of BMP6 signaling on vessel
morphology, it is likely that proangiogenic BMP and VEGF-A
signaling may function in a distinct manner. For instance,
BMP6 stimulation is only able to increase the vessel diam-
eter, which is consistent with the recent finding that BMP
signaling is proangiogenic without increasing cell proliferation
(Finkenzeller et al., 2012). VEGF-A, in turn, only promotes
an increase in the vascular coverage (Figures 3A and 3B;
Figure S1H).r Inc.
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Dab2 Mediates BMP Signaling in Endothelial CellsDAB2, BMPRII, and Clathrin Are Closely Associated
Considering that DAB2 is a cargo-specific adaptor protein for
Clathrin, it is possible that DAB2 may mediate interactions
between BMP type II receptors and Clathrin on cell membranes.
In the zebrafish genome, two clathrin heavy polypeptide genes,
cltca and cltcb exist with cltca being preferentially expressed
in endothelial cells and blood (Sprague et al., 2006; Trinh et al.,
2011). In accordance with its expression pattern, MO mediated
knockdown of cltca caused severe defects in the formation of
blood vessels, including intersegmental vessels (ISVs) and the
CVP (Figures S3A and S3B). While the defects in ISVs are likely
due to the decreased Vegf-A signaling (Lampugnani et al.,
2006), the similarities between CVP phenotypes of cltca and
dab2 MO-injected embryos support the idea that Dab2 may
mediate interactions between Clathrin and the Bmp2b signaling
complex in endothelial cells (Figure S3C).
To further delineate the functional relationship among DAB2,
Clathrin, and the BMP2 signaling complex, we examined the
association of DAB2 with BMPRII and Clathrin. Since it has been
suggested that BMPRII undergoes constant internalization (Har-
tung et al., 2006), we examined the interaction in unstimulated
HUVECs and found that DAB2, BMPRII, and Clathrin colocalize
with one another (Figure 3C), suggesting that these molecules
may form a complex. Moreover, in situ proximity ligation assay
(PLA), which detects colocalization of two proteins within
a 40 nm distance of one another (So¨derberg et al., 2006), showed
a positive PLA signal between DAB2 and BMPRII, DAB2 and Cla-
thrin, and BMPRII and Clathrin (Figures 3D and S3D). Although
treatment with DAB2 or BMPRII siRNA significantly decreased
the number of positive PLA signals per cell, treatment with
BMP6did not increase the interaction betweenDAB2andBMPRII
(Figures 3D, 3E, andS3E), suggesting that constant internalization
of BMPRII may be dependent on DAB2 function. Furthermore,
antibodies against DAB2 pulled down endogenous BMPRII
protein from HUVEC lysate, suggesting a physical association
between these two proteins (Figure 3F). Taken together, our
data indicate thatDAB2andBMPRIIare likely tophysically interact
with each other within a Clathrin-coated pit in endothelial cells.
DAB2 Promotes the Internalization of BMP Signaling
Complex in Endothelial Cells
Our data suggest that DAB2 is likely to regulate BMP signaling by
promoting the internalization of the BMP ligand receptor
complex. To test this idea, we examined the effects of DAB2
knockdown on the internalization of BMPRII by measuring the
amount of membrane-retained BMPRII using fluorescence-acti-
vated cell sorting (FACS). In unstimulated HUVECs treated with
DAB2 siRNA, we found that membrane-retained BMPRII was
significantly increased compared to control siRNA-treated
HUVECs, suggesting that DAB2 function may be essential for
internalization of BMPRII (Figure 4A).
To test the contribution of BMPRII internalization to BMP
signaling, we examine the effects of exogenous ligand stimula-
tion on BMPRII internalization. In BMP6-stimulated HUVECs, bi-
otinylation assay showed that the amount of internalized BMPRII
significantly increased within 30 min of BMP6 treatment (Fig-
ure 4B), indicating that the presence of ligand accelerates the
internalization of BMPRII. In the absence of DAB2, the amount
of BMPRII on the surface was significantly increased in both un-Developstimulated and BMP6-stimulated DAB2 siRNA-treated HUVECs
(Figure 4C). Furthermore, the amount of internalized BMPRII and
ALK3 (BMPRIA) upon ligand activation was drastically reduced
in DAB2 siRNA-treated HUVECs (Figures 4D and S4A).
Combined, our data show that DAB2 is a critical regulator for
the internalization of BMP receptors, suggesting that DAB2 is
not only required for constant internalization of BMP receptors
in unstimulated cells but is also essential for ligand-activated
internalization of BMP receptors.
Since DAB2 appears to be essential for the internalization of
the BMP2 signaling complex, inhibition of DAB2 should abolish
Clathrin-mediated endocytosis of BMP receptors, therefore
attenuating phosphorylation of SMADs. To test this possibility,
we examined the effects of DAB2manipulation on the phosphor-
ylation of SMADs in HUVECs. Consistent with our data, phos-
phorylation of SMAD-1, 5, and 8 was drastically decreased in
DAB2 siRNA-treated HUVECs under unstimulated and BMP6-
stimulated conditions (Figures 4E, 4F, and S4B), suggesting
that internalization of the BMP signaling complex is required to
promote phosphorylation of SMADs.
Our study demonstrates that Dab2 is an essential regulator of
venous morphogenesis by mediating transduction of Bmp2b
signaling. Moreover, we found that DAB2 is physically associ-
ated with BMPRII and Clathrin, and functions as a key regulator
for the internalization of BMP receptors. By modulating internal-
ization of the BMP signaling complex, DAB2 regulates outcomes
of BMP signaling in HUVECs (Figure 4G). Since BMPRII is the
obligatory component of the heterotetrameric signaling complex
for all BMP ligands (Ehrlich et al., 2011; Little and Mullins, 2009),
it is likely that DAB2 may mediate signaling of diverse BMP
ligands. A recent report on the role of Fcho1/2, a Dab2 interact-
ing protein, in the internalization of Alk2 (Umasankar et al., 2012),
further supports this notion. Taken together, it is likely that inter-
actions among DAB2, Clathrin, and BMPRII provide a molecular
basis of the context dependent proangiogenic function of
BMP2/6 signaling.
EXPERIMENTAL PROCEDURES
Zebrafish Husbandry, Heat-Shock Treatment, and MO Injection
Using zebrafish and all experiments were approved by the IACUC of Yale
University. Wild-type zebrafish (Danio rerio) and their embryos were raised
as previously described (Westerfield, 2000). Heat-shock treatment and MO
injection were performed as previously described (Wiley et al., 2011). The effi-
cacy of Bmp2b induction was verified by p-SMAD-1/5/8 antibody staining. List
of the fish lines and the sequences of MO used in this study are listed in the
Supplemental Experimental Procedures.
In Situ Hybridization and Immunohistochemistry
In situ hybridization and immunohistochemistry were performed as previously
described (Wiley et al., 2011). The antibodies and recombinant proteins used
for this study can be found in the Supplemental Experimental Procedures.
siRNA Transfection and Fibrin Gel Assay
HUVECs were transfected with Human DAB2 or nontargeted control siRNA
(Dharmacon, Lafayette, CO, USA) for DAB2 knockdown and Hs_BMPR2_5
flexiTube siRNA (S100604996) and Allstars negative control (Qiagen, Venlo,
the Netherlands) for BMPRII knockdown. siRNA was used at a concentration
of 50 nM for DAB2 and 20 nM for BMPRII using Oligofectamine (Invitrogen,
Carlsbad, CA, USA) transfectant. After 24 hr, HUVECs (250,000 cells/well
in 24-well plates) were resuspended in 300 ml fibrinogen solution (2.5 mg/ml)
in EBM-2 (Lonza, Basel, Switzerland) supplemented with 2% FBS andmental Cell 23, 441–448, August 14, 2012 ª2012 Elsevier Inc. 445
Figure 4. DAB2 Promotes Internalization of BMP2 Signaling Complex and Modulates Downstream SMAD Phosphorylation
(A) FACS analysis using antibody against the extracellular region of BMPRII on control or DAB2 siRNA-treated HUVECs. n = 5.
(B) Internalization of BMPRII upon ligand stimulation. The amount of internalized BMPRII wasmeasured by biotinylation assay in BMP6-treated HUVECs at 0, 15,
and 30 min after treatment (50 ng/ml).
(C) Surface localized BMPRII in control or DAB2 siRNA-treated HUVECs upon BMP6 stimulation (50 ng/ml).
(D) Internalized BMPRII in control or DAB2 siRNA-treated HUVECs upon BMP6 stimulation (50 ng/ml). See also Figure S4A.
(E) Fluorescencemicrographs of control orDAB2 siRNA-treated HUVECs, stained for DAB2 (left), p-SMAD-1,5/8 (middle), and SMAD-1 (right). Arrowhead points
to residual DAB2 expression cell in knockdown sample. Scale bar is 10 mm. See also Figure S4B.
(F) Quantification. The gray value of p-SMAD-1, 5/8 and SMAD-1 within nuclei was measured. n = 3, and total number of images was 14 (Control) or 16 (DAB2
siRNA) and **p < 0.001.
(G) Schematic model. DAB2 is essential for the internalized of BMP signaling complex and subsequent phosphorylation of SMADs.
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ogen solution clotted with 1 U thrombin for 20 min at 37C). The secondary
layer of fibrin was clotted for 1 hr at 37C. C3H10T1/2 (250,000 cells/well), in
EBM-2 supplemented with 2% FBS and 25 ng/ml VEGF-A, were then plated
on top of the fibrin layers and cultures were incubated at 37C and 5% CO2.
Control cultures were grown with VEGF for 2–3 days. VEGF was then removed
and cultures were grown for another 2–3 days. VEGF and/or BMP6 were
added after 2–3 days for the induction conditions. After 3–5 days, cultures
were labeled with 4 mg/ml Calcein AM (Invitrogen) for 1 hr and imaged by fluo-
rescence microscopy using a standard FITC filter (Larrive´e et al., 2012).
Western, Immunoprecipitation Assay, and FACS Analysis in HUVEC
HUVECs were cultured on 0.1% gelatin-coated plates in complete endothelial
cell growth media containing supplements (Lonza, CC-3162) and 100 unit/ml
penicillin-streptomycin. Cells between passages 3 and 7 were used for anal-
yses. For immunoprecipitation, Protein A/G PLUS-Agarose Immunoprecipita-
tion Reagent (Santa Cruz Biotechnology, Santa Cruz, CA, USA) was used
according to manufacturer’s instructions. For FACS analyses, HUVECs were
stained with FITC conjugated antibody that recognized the extracellular
domain of BMPRII (Santa Cruz Biotechnology; SC-13704, 1:200) without a per-
meablization process and were subsequently sorted for fluorescence.
In Situ Proximity Ligation Assay
Cells were grown overnight on a 16-well glass slide (Thermo Scientific, Ro-
chester, NY, USA), starved for 5–6 hr in serum-free EBM, and stimulated
with recombinant human BMP6 (50 ng/ml) for 30 min. In situ PLA was per-
formed in accordance with the manufacturer’s protocol using a Duolink Detec-
tion Kit (Olink Bioscience, Uppsala, Sweden).446 Developmental Cell 23, 441–448, August 14, 2012 ª2012 ElsevieImage Acquisition, Processing, and Quantification
Image acquisition from zebrafishwas performed using aNikon confocal micro-
scope and depth coded with ImageJ. For immunocytochemistry, fixed
HUVECs cultured on an 8-well glass slide (Thermo Scientific) were imaged
using the 633 objective of a Nikon confocal microscope.
Number of branches and mean pixel intensity of ectopic vessels were
quantified in order to assess the severity of Bmp2b-induced angiogenesis
in Figure 1C. To calculate mean pixel intensity, four to five focal planes
that contained ectopic vessels from the entire z stack were flattened and
adjusted by Adobe Photoshop and MBF ImageJ. To quantify ventral sprouts
from the CVP shown in Figure 1E, all sprouts projecting toward the ventral
side of the anterior-posterior axis in 25 to 26 hpf embryos were counted.
To assess the effects of MO injection on the formation of CVP in Figure 2B,
somites with anastomosed ventral sprouts were given the value of 1, while
those without were given the value of 0, and the percentage of somites
with the value 1 was calculated as previously shown (Wiley et al., 2011).
To assess the amount of SMAD protein within the nucleus in Figure 4F, six
nuclei from each image were randomly selected and gray values of pixel
intensity corresponding to the longer axis of nucleus were measured and
quantified. For HUVEC Fibrin gel assay, images were analyzed by PRISM
and ImageJ program. All graphs were generated by Microsoft Excel
program.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, Supplemental Experimental
Procedures, and one movie and can be found with this article online at
http://dx.doi.org/10.1016/j.devcel.2012.07.007.r Inc.
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